Epista Life Science A/S
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Epista Life Science A/S - overview
Established
2009
Location
Horsholm, -, Denmark
Primary Industry
Software
About
Based in Denmark, Epista Life Science A/S operates as a healthcare company that provides general consulting, software implementation, and managed operations for healthcare industries. In May 2022, FSN Capital agreed to acquire a majority stake in Epista Life Science A/S. As of October 2022, Klavs Esbjerg is the Chief Executive Officer (CEO) of the company. Epista Life Science A/S company offers needs analysis and system selection, process optimization, implementation management, and maintenance software, enabling the client to balance risk and efficiency to achieve more.
The acquisition plans Epista Life Science A/S to continue to support its global force for a positive impact in the life science market through further M&A and organic growth.
Current Investors
FSN Capital
Primary Industry
Software
Sub Industries
Consulting Services, Healthcare IT, Legal Software, Medical Software
Website
www.epista.com
Verticals
Artificial Intelligence, Big Data, Cloud Computing, HealthTech, RegTech
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Epista Life Science A/S - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Epista Life Science A/S | - |
Displaying 1 - 1 of 1
Epista Life Science A/S - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.